Latest news with #EntrepreneuroftheYear®
Business Upturn
23-05-2025
- Automotive
- Business Upturn
Force Marketing Named 2025 Georgia Fast 40 Honoree and EY Entrepreneur of the Year Finalist in the Southeast
By GlobeNewswire Published on May 24, 2025, 00:57 IST Atlanta, May 23, 2025 (GLOBE NEWSWIRE) — Force Marketing, a data-driven technology and marketing leader in the automotive industry, has been named a 2025 Georgia Fast 40 honoree by ACG Atlanta and celebrates CEO John Fitzpatrick's nomination as a finalist for Ernst & Young's Entrepreneur of the Year® Southeast Region. The recognitions mark a breakout moment for the company, which has quietly been growing at a rapid but sustained pace behind the scenes—and is now turning heads across the industry. 'While we're certainly proud of our consistent 25% year-over-year growth for the past three years, we're equally, if not more, excited about our 95% client retention rate,' said Fitzpatrick. 'That's the real foundation of our momentum. Our OEM and dealer partners are growing with us, and we're bringing even more dealers into the fold. That kind of impact is what makes milestones like these award recognitions truly meaningful.' Long known as a legacy name in automotive marketing, Force is rewriting the playbook with a unified data tech stack–including its automotive-specific CDP, Audience IQ–that supports both variable and fixed operations. The company's acquisition of GSM (Gulf States Toyota's longtime marketing partner) in 2021 was a major turning point, giving Force unmatched depth in after sales loyalty and lifecycle marketing. Audience IQ houses a full-stack suite of solutions including DRIVE (streaming CTV pre-market & in-market audiences), Conquest Connect, Recapture and ATOM, Force empowers dealers with proprietary audience targeting, dynamic creative and end-to-end retention tools that drive results across every dealership department. 'Our growth story is powered by people,' added Fitzpatrick. 'We have world-class team member retention—over 95% for the last three years—all while operating fully remote with 115 team members across 21 states and counting. Our team is the secret sauce behind every milestone, every innovation, and every client success story.' As Force expands and continues delivering results for OEMs and dealer groups across the country, one thing is clear: this isn't just growth— it's evolving the way dealers connect with their customers. About Force Marketing Founded in 2006, Force Holdings, LLC is a leading marketing technology provider to the automotive industry whose family of brands includes: Force Marketing, WeDrive Automotive and Gulf States Marketing (GSM). Headquartered in Atlanta with over 110 team members strategically positioned all over the U.S., the Force Family of Brands focuses on partnering and fostering relationships with dealers and OEMs nationwide to maximize ROAS, speed to market and improved lifetime customer value metrics. More information about Force Marketing's comprehensive suite of tech-enabled products can be found at . Attachment Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Yahoo
23-05-2025
- Automotive
- Yahoo
Force Marketing Named 2025 Georgia Fast 40 Honoree and EY Entrepreneur of the Year Finalist in the Southeast
Force Marketing is entering a defining chapter as they have evolved from a legacy automotive agency into a modern, data-powered marketing tech partner driving growth, loyalty, and national recognition Force Marketing Atlanta, May 23, 2025 (GLOBE NEWSWIRE) -- Force Marketing, a data-driven technology and marketing leader in the automotive industry, has been named a 2025 Georgia Fast 40 honoree by ACG Atlanta and celebrates CEO John Fitzpatrick's nomination as a finalist for Ernst & Young's Entrepreneur of the Year® Southeast Region. The recognitions mark a breakout moment for the company, which has quietly been growing at a rapid but sustained pace behind the scenes—and is now turning heads across the industry. 'While we're certainly proud of our consistent 25% year-over-year growth for the past three years, we're equally, if not more, excited about our 95% client retention rate,' said Fitzpatrick. 'That's the real foundation of our momentum. Our OEM and dealer partners are growing with us, and we're bringing even more dealers into the fold. That kind of impact is what makes milestones like these award recognitions truly meaningful.' Long known as a legacy name in automotive marketing, Force is rewriting the playbook with a unified data tech stack–including its automotive-specific CDP, Audience IQ–that supports both variable and fixed operations. The company's acquisition of GSM (Gulf States Toyota's longtime marketing partner) in 2021 was a major turning point, giving Force unmatched depth in after sales loyalty and lifecycle marketing. Audience IQ houses a full-stack suite of solutions including DRIVE (streaming CTV pre-market & in-market audiences), Conquest Connect, Recapture and ATOM, Force empowers dealers with proprietary audience targeting, dynamic creative and end-to-end retention tools that drive results across every dealership department. 'Our growth story is powered by people,' added Fitzpatrick. 'We have world-class team member retention—over 95% for the last three years—all while operating fully remote with 115 team members across 21 states and counting. Our team is the secret sauce behind every milestone, every innovation, and every client success story.' As Force expands and continues delivering results for OEMs and dealer groups across the country, one thing is clear: this isn't just growth— it's evolving the way dealers connect with their customers. About Force Marketing Founded in 2006, Force Holdings, LLC is a leading marketing technology provider to the automotive industry whose family of brands includes: Force Marketing, WeDrive Automotive and Gulf States Marketing (GSM). Headquartered in Atlanta with over 110 team members strategically positioned all over the U.S., the Force Family of Brands focuses on partnering and fostering relationships with dealers and OEMs nationwide to maximize ROAS, speed to market and improved lifetime customer value metrics. More information about Force Marketing's comprehensive suite of tech-enabled products can be found at Attachment Force Marketing CONTACT: Media Contacts: Kerry Crump, kcrump@ Kelly Frommer, kfrommer@ in to access your portfolio
Yahoo
24-02-2025
- Business
- Yahoo
DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors
MINNEAPOLIS, February 24, 2025--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on acute ischemic stroke and preeclampsia, today announced the election of Daniel J. O'Connor to its Board of Directors, effective February 20, 2025. Mr. O'Connor has decades of executive experience and leadership in the biopharmaceutical industry, including as CEO and other executive level leadership positions at Ambrx Biopharma, Inc. (Ambrx), ImClone Systems Incorporated, Bracco Diagnostics, and PharmaNet (today, Syneos Health). Mr. O'Connor has gained a reputation as a seasoned and successful biopharma CEO, most recently serving as President, Chief Executive Officer and Director of Ambrx, where under his leadership the company grew from a $40 million valuation upon him joining the company to being acquired by Johnson & Johnson for $2 billion just 14 months later. His expertise spans across capital markets, licensing transactions, business development, corporate strategy, clinical development and regulatory compliance, making him a valuable addition to DiaMedica's Board. "DiaMedica's progress over the past twelve months is highly impressive and attributable to its efforts to provide new treatment options for acute ischemic stroke (AIS) and preeclampsia (PE), both areas of high unmet medical need," stated Mr. O'Connor. "AIS is the leading cause of combined mortality and morbidity worldwide, and 87% of all strokes are ischemic. PE is a major pregnancy complication that contributes to high rates of mortality and morbidity in pregnant women. There are 50,000 severe cases of preeclampsia in the United States every year, and the problem is worsening. I am thrilled by the work that DiaMedica is doing to define new treatments for AIS and PE and look forward to partnering with the board and DiaMedica's experienced management team to help advance the company's important pipeline." Beyond his executive leadership, Mr. O'Connor has served on the boards of multiple public companies and non-profit entities. Mr. O'Connor has leveraged his experience to guide and support life science companies, serving on the Board of Trustees of BioNJ for several years, including several years as its Vice Chairman. He has received several awards, including being named the Ernst & Young Entrepreneur of the Year® in New Jersey while President, CEO and Director of Advaxis, Inc. He is a 1988 graduate from the United States Marines Corps Officer Candidate School, attained the rank of Captain while serving in the U.S. Marines and was deployed to Saudi Arabia for Operation Desert Shield. Mr. O'Connor holds a BA from Boston University and a JD from Penn State Dickinson Law. "We are thrilled to welcome Dan to our Board," said Rick Pauls, President and Chief Executive Officer of DiaMedica. "His extensive experience leading biotech companies through critical growth phases, combined with his deep understanding of corporate governance and strategic development, will be invaluable as we continue advancing our pipeline and executing our mission to bring transformative therapies to patients." About DM199 DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1 (rhKLK1) in clinical development for acute ischemic stroke and preeclampsia. KLK1 is a serine protease enzyme that plays an important role in the regulation of diverse physiological processes via a molecular mechanism that increases production of nitric oxide, prostacyclin and endothelium-derived hyperpolarizing factors. In the case of AIS, DM199 is intended to enhance blood flow and boost neuronal survival in the ischemic penumbra by dilating arterioles surrounding the site of the vascular occlusion and inhibition of apoptosis (neuronal cell death) while also facilitating neuronal remodeling through the promotion of angiogenesis. In preeclampsia, DM199 is intended to lower blood pressure, enhance endothelial health and improve perfusion to maternal organs and the placenta. About DiaMedica Therapeutics Inc. DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from serious ischemic diseases with a focus on acute ischemic stroke and preeclampsia. DiaMedica's lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases. For more information visit the Company's website at View source version on Contacts Scott KellenChief Financial OfficerPhone: (763) 496-5118skellen@ For Investor Inquiries: Mike MoyerManaging Director, LifeSci Advisors, LLCmmoyer@ Sign in to access your portfolio
